Tag: ASX:FPH

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.

Watch the short-term momentum indicators for a turn higher.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.

Watch the short-term momentum indicators for a turn higher.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now within our highlighted range.

Watch the short-term momentum indicators for a turn higher.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is a current holding in our ASX100 model portfolio.

The stock is expensive at almost 50x PE and investors should consider trading out of the recent rally should the short-term momentum indicators turn lower.

Resistance is likely to form within the $33.50 to $35 price range.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Investors should consider a buy-write strategy to enhance the income return. For more detail please call our office on 1300 614 002.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Investors should consider a buy-write strategy to enhance the income return. For more detail please call our office on 1300 614 002.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Investors should consider a buy-write strategy to enhance the income return. For more detail please call our office on 1300 614 002.

Fisher & Paykel Healthcare Corporation is under Algo Engine buy conditions and is now consolidating above the $30 support level.

Investors should consider a buy-write strategy to enhance the income return. For more detail please call our office on 1300 614 002.